Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.

Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Rasmussen JV, Hilden J, Boutron I, Ravaud P, Brorson S.

Int J Epidemiol. 2014 Jun;43(3):937-48. doi: 10.1093/ije/dyt270. Epub 2014 Jan 21. Review.

PMID:
24448109
2.

Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors.

Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S.

CMAJ. 2013 Mar 5;185(4):E201-11. doi: 10.1503/cmaj.120744. Epub 2013 Jan 28. Review.

3.

Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.

Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S.

BMJ. 2012 Feb 27;344:e1119. doi: 10.1136/bmj.e1119. Review.

PMID:
22371859
4.

Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias.

Bello S, Krogsbøll LT, Gruber J, Zhao ZJ, Fischer D, Hróbjartsson A.

J Clin Epidemiol. 2014 Sep;67(9):973-83. doi: 10.1016/j.jclinepi.2014.04.008. Epub 2014 Jun 25. Review.

PMID:
24972762
5.

Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?

Poolman RW, Struijs PA, Krips R, Sierevelt IN, Marti RK, Farrokhyar F, Bhandari M.

J Bone Joint Surg Am. 2007 Mar;89(3):550-8. Review.

PMID:
17332104
6.
7.

Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies.

Hróbjartsson A, Emanuelsson F, Skou Thomsen AS, Hilden J, Brorson S.

Int J Epidemiol. 2014 Aug;43(4):1272-83. doi: 10.1093/ije/dyu115. Epub 2014 May 30. Review.

8.

Placebo interventions for all clinical conditions.

Hróbjartsson A, Gøtzsche PC.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003974. doi: 10.1002/14651858.CD003974.pub3. Review.

PMID:
20091554
9.
10.

Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.

Boutron I, Estellat C, Guittet L, Dechartres A, Sackett DL, Hróbjartsson A, Ravaud P.

PLoS Med. 2006 Oct;3(10):e425. Review.

11.

Blinding of outcomes in trials of orthopaedic trauma: an opportunity to enhance the validity of clinical trials.

Karanicolas PJ, Bhandari M, Taromi B, Akl EA, Bassler D, Alonso-Coello P, Rigau D, Bryant D, Smith SE, Walter SD, Guyatt GH.

J Bone Joint Surg Am. 2008 May;90(5):1026-33. doi: 10.2106/JBJS.G.00963. Review.

PMID:
18451395
12.
13.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
14.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

15.

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA.

BMJ. 2008 Mar 15;336(7644):601-5. doi: 10.1136/bmj.39465.451748.AD. Epub 2008 Mar 3.

16.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

17.

[Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].

Li XQ, Ling CQ.

Zhong Xi Yi Jie He Xue Bao. 2012 Dec;10(12):1341-62. doi: 10.3736/jcim20121204. Review. Chinese. Retraction in: J Integr Med. 2013 Mar;11(2):151.

PMID:
23257126
18.

Blinding in randomized clinical trials: imposed impartiality.

Hróbjartsson A, Boutron I.

Clin Pharmacol Ther. 2011 Nov;90(5):732-6. doi: 10.1038/clpt.2011.207. Epub 2011 Oct 12.

PMID:
21993424
19.

DEPERROR: Risks of systematic errors in drug and non-drug randomized clinical trials assessing intervention effects in patients with unipolar depression.

Krogh J, Hjorthøj CR, Jakobsen JC, Lindschou J, Kessing LV, Nordentoft M, Gluud C.

J Affect Disord. 2015 Jul 1;179:121-7. doi: 10.1016/j.jad.2015.03.042. Epub 2015 Apr 1. Review.

PMID:
25863907
20.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900

Supplemental Content

Support Center